SDX-105
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SDX-105, covering 2014-05-09 to 2014-05-09. Get the full timeline:
Most recent: Clinical Trial Update: SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL) [Phase 2]